We are committed to improving the care we give to women and their families, which is why we offer our patients the chance to get involved in clinical research studies. There are lots of types of research, from lifestyle surveys to drug trials. Through research we can find out:

  • Which treatments are most effective for women
  • Develop the advice and information we offer to patients
  • Assess what is acceptable to women in our care and where specialist support is needed.

Our research is funded by the National Institute of Health and Care Research, and reviewed and approved by UK regulatory bodies. We ensure that research is ethically and scientifically sound and undertaken to the highest standard for patient safety.

Taking part in our research is optional. If we offer you the chance to participate, you will be given written information, and plenty of time to ask questions and find out more before you decide. Keep a look out in the clinical areas, on social media and on our website for information about different students we are currently participating in. Your clinicians may also discuss specific studies directly with you if they are relevant and suitable for your care.

Please also feel free to contact us yourself via email at sash.researchmidwives@nhs.net – we would love to hear from you!

iGBS3

Development of a serocorrelate of protection against invasive Group B Streptococcus disease (iGBS).

OBS-UK study

Looking at implementing a new bundle of care for the management of postpartum haemorrhage

SNAP-2 - The University of Nottingham

The Smoking, Nicotine and Pregnancy (SNAP-2) research trial is testing a package of support to assist pregnant women to stop smoking by helping them to make better use of Nicotine Replacement Therapy (NRT).

This is a randomised study where women will be randomly assigned to one of two groups:

  1. One group of women will receive usual care to help stop smoking.  We already know that this care helps pregnant women and is known as the ‘Gold Standard’ of care.
  2. The second group will receive usual care PLUS a new package of support.